467
Participants
Start Date
April 30, 2008
Primary Completion Date
May 31, 2009
Study Completion Date
November 30, 2009
Exenatide Once Weekly
subcutaneous injection, 2.0mcg, once weekly
Insulin Glargine
subcutaneous injection, variable dose, QD
Research Site, Escondido
Research Site, Jacksonville
Research Site, Orlando
Research Site, West Palm Beach
Research Site, Honolulu
Research Site, Idaho Falls
Research Site, Minneapolis
Research Site, St Louis
Research Site, Dayton
Research Site, Ada
Research Site, San Antonio
Research Site, Spokane
Research Site, Wollongong
Research Site, Herston
Research Site, Adelaide
Research Site, Keswick
Research Site, Box Hill
Research Site, Geelong
Research Site, Brussels
Research Site, Edegem
Research Site, Mělník
Research Site, Prague
Research Site, Stodůlky
Research Site, Aalborg
Research Site, Arhus C
Research Site, Herlev
Research Site, Køge
Research Site, Angers
Research Site, Corbeil Essoness
Research Site, Nancy
Research Site, Nanterre
Research Site, Toulouse
Research Site, Bad Mergentheim
Research Site, Dresden
Research Site, Essen
Research Site, Falkensee
Research Site, Fulda
Research Site, Münster
Research Site, Othmarschen
Research Site, Rothenburg An Der Fulda
Research Site, Speyer
Research Site, Athens
Research Site, Thessaloniki
Research Site, Budapest
Research Site, Eger
Research Site, Gyula
Research Site, Pécs
Research Site, Mexico City
Research Site, Mérida
Research Site, Tampico
Research Site, Tijuana
Research Site, Amsterdam
Research Site, Gouda
Research Site, Hoogeveen
Research Site, Rotterdam
Research Site, Zwijndrecht
Research Site, Zwolle
Research Site, Caguas
Research Site, Yabucoa
Research Site, Moscow
Research Site, Rostov-on-Don
Research Site, Saint Petersburg
Research Site, Gyeonggi-do
Research Site, Seoul
Research Site, Alicante
Research Site, Alzira-Valencia
Research Site, Barcelona
Research Site, Bilbao
Research Site, Madrid
Research Site, Málaga
Research Site, Teruel
Research Site, Chiayi City
Research Site, Tainan County
Research Site, Taipei
Research Site, Taoyuan District
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY